The dilemma of monotherapy or combination therapy in community-acquired pneumonia.

@article{Vardakas2017TheDO,
  title={The dilemma of monotherapy or combination therapy in community-acquired pneumonia.},
  author={Konstantinos Z. Vardakas and Kyriakos K Trigkidis and Katerina N Apiranthiti and Matthew E. Falagas},
  journal={European journal of clinical investigation},
  year={2017},
  volume={47 12}
}
SCOPE To study the factors associated with mortality in hospitalized patients with community-acquired pneumonia treated with monotherapy or combination therapy. METHODS PubMed and Scopus were searched. Patients receiving macrolides, β-lactams and fluoroquinolones, as monotherapy or in combination, were included. Meta-analyses and meta-regressions were performed. RESULTS Fifty studies were included. Overall, monotherapy was not associated with higher mortality than combination (RR 1.14, 95… CONTINUE READING
0 Citations
71 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 71 references

beta-Lactam monotherapy vs beta- This article is protected by copyright

  • N. Garin, D. Genne, +11 authors A. Perrier
  • All rights reserved. lactam-macrolide…
  • 2014
2 Excerpts

Contribution of host

  • P. Naucler, J. Darenberg, E. Morfeldt, A. Ortqvist, B. Henriques Normark
  • bacterial factors and antibiotic treatment to…
  • 2013
2 Excerpts

Similar Papers

Loading similar papers…